| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Center for Research Resources (NCRR) Urological Research Foundation |
| Information provided by: | National Center for Research Resources (NCRR) |
| ClinicalTrials.gov Identifier: | NCT00035217 |
Purpose
There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer and how different treatments affect the patient's quality of life. The purpose of this research is to describe the disease course of prostate cancer and to determine the effectiveness, potential complications, and quality of life after different treatments in men with prostate cancer detected via screening with prostate-specific antigen (PSA) and/or digital rectal examination
| Condition |
|
Prostate Cancer |
| MedlinePlus related topics: | Cancer Prostate Cancer |
| Study Type: | Observational |
| Study Design: | Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study |
| Official Title: | Follow-Up Study for Men Diagnoses With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program |
Eligibility
| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Men with prostate cancer diagnosed through the PSA screening study
Contacts and Locations| United States, Missouri | |||||
| Washington University School of Medicine | |||||
| St. Louis, Missouri, United States, 63110 | |||||
| National Center for Research Resources (NCRR) |
| Urological Research Foundation |
More Information
| Study ID Numbers: | NCRR-M01RR00036-0838 |
| First Received: | May 2, 2002 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00035217 |
| Health Authority: | United States: Federal Government |
|
|
|
